Editas Medicine
Editas Medicine Raises $118M in Follow-on Offering
Quick Facts
Editas Medicine Raises $118M in Follow-on Offering
Editas Medicine has successfully raised $118M in a Follow-on Offering at a $1.8B valuation led by Polaris Partners, Flagship Pioneering, Third Rock Ventures, Google Ventures.
Company Overview
Editas Medicine is a Biotech company headquartered in 11 Hurley Street, Cambridge, MA 02141, founded in 2013 with 300+ employees.
Genome editing medicines
Fundraising Details
- Amount Raised: $118M
- Round Type: Follow-on Offering
- Valuation: $1.8B
- Date: 2024-10-18
- Investors: Polaris Partners, Flagship Pioneering, Third Rock Ventures, Google Ventures
About Editas Medicine
Genome editing medicines The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: 11 Hurley Street, Cambridge, MA 02141
- Founded: 2013
- Team Size: 300+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Editas Medicine's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Editas Medicine's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $1.8B valuation marks an important milestone for Editas Medicine, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Editas Medicine is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
This fundraising news was reported on 2024-10-18. For more information about Editas Medicine, visit their headquarters at 11 Hurley Street, Cambridge, MA 02141.
About the Author

Related Company Reports
Anthropic Raises $2B in Series D
Anthropic, a AI/ML company based in San Francisco, CA, has raised $2B in Series D at a $18B valuation led by Menlo Ventures, Spark Capital, Google.

xAI Raises $6B in Series C
xAI, a AI/ML company based in San Francisco, CA, has raised $6B in Series C at a $40B valuation led by Sequoia Capital, a16z, Valor Equity.

Adept AI Raises $350M in Series B
Adept AI, a AI/ML company based in San Francisco, CA, has raised $350M in Series B at a $1B valuation led by General Catalyst, Spark Capital, Addition.
